Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan

NCT01051960 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Systemic Sclerosis
Shortness of Breath
Pulmonary Hypertension

Interventions

DRUG: Ambrisentan

Sponsor

University of California, Los Angeles

Collaborators

[object Object]